Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6

Autor: F, Facciotti, P, Larghi, R, Bosotti, C, Vasco, N, Gagliani, C, Cordiglieri, S, Mazzara, V, Ranzani, E, Rottoli, S, Curti, A, Penatti, B, Karnani, Y, Kobayashi, M, Crosti, M, Bombaci, J P, van Hamburg, G, Rossetti, R, Gualtierotti, M, Gerosa, S, Gatti, S, Torretta, L, Pignataro, S W, Tas, S, Abrignani, M, Pagani, F, Grassi, P L, Meroni, R A, Flavell, J, Geginat

Publikováno v: Proc Natl Acad Sci U S A

Interleukin 10 (IL-10) is an antiinflammatory cytokine, but also promotes B cell responses and plays a pathogenic role in systemic lupus erythematosus (SLE). CD4(+)CCR6(+)IL-7R(+)T cells from human tonsils produced IL-10 following stimulation by naï

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db23ab2fd6a065ba4c376e117b1bf287
https://pubmed.ncbi.nlm.nih.gov/32184325

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period:a multicentre prospective study of 1000 patients

Autor: R, Cervera, R, Serrano, G J, Pons-Estel, L, Ceberio-Hualde, Y, Shoenfeld, E, de Ramón, V, Buonaiuto, S, Jacobsen, M M, Zeher, T, Tarr, A, Tincani, M, Taglietti, G, Theodossiades, E, Nomikou, M, Galeazzi, F, Bellisai, P L, Meroni, R H W M, Derksen, P G D, de Groot, M, Baleva, M, Mosca, S, Bombardieri, F, Houssiau, J-C, Gris, I, Quéré, E, Hachulla, C, Vasconcelos, A, Fernández-Nebro, M, Haro, Z, Amoura, M, Miyara, M, Tektonidou, G, Espinosa, M L, Bertolaccini, M A, Khamashta, Manuel, Abarca

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2015, 74 (6), pp.1011-1018. ⟨10.1136/annrheumdis-2013-204838⟩
Annals of the Rheumatic Diseases, 74(6), 1011. BMJ Publishing Group
Dipòsit Digital de la UB
Universidad de Barcelona

ObjectivesTo assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later.MethodsIn 1999, we s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e3ac6885b0418cc1af25f2f47e7f01
http://hdl.handle.net/11568/565479

Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype

Autor: P L, Meroni, E, Raschi, C, Testoni, A, Tincani, G, Balestrieri, R, Molteni, M A, Khamashta, E, Tremoli, M, Camera

Publikováno v: Arthritis and rheumatism. 44(12)

To investigate the ability of statins, the inhibitors of the hydroxymethylglutaryl-coenzyme A reductase enzyme, to affect endothelial cell activation induced by anti-beta2-glycoprotein I (anti-beta2GPI) antibodies in vitro.Human umbilical vein endoth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::17dcaa6cf11e1860f7292c852dc333f3
https://pubmed.ncbi.nlm.nih.gov/11762948

Autoimmune vasculitis: a good clinical and basic exercise

Autor: P L, Meroni, N, Del Papa

Publikováno v: Clinical reviews in allergyimmunology. 15(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::83a48595b809e408182ee3154a3ec863
https://pubmed.ncbi.nlm.nih.gov/9209797

Clinical significance of the anti-endothelial antibodies

Autor: P L, Meroni

Publikováno v: Israel journal of medical sciences. 30(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00d98e8700fbb306626b8d1c0826d195
https://pubmed.ncbi.nlm.nih.gov/8181930